Kontafarma China Holdings Limited (HKG:1312)

Kontafarma China Holdings Revenue

Kontafarma China Holdings had revenue of 383.35M HKD in the half year ending June 30, 2026, a decrease of -16.39%. This brings the company's total for the last twelve months to 845.33M, down -5.20% year-over-year. In the year 2025, Kontafarma China Holdings had annual revenue of 914.71M with 1.92% growth. That makes Kontafarma China Holdings the 22,087th largest company in the world by revenue and 1,291st in Hong Kong.

• Revenue (ttm): 845.33M
• Revenue Growth: -5.20%
• P/S Ratio: 0.18
• Revenue / Employee: 1.35M
• Employees: 625
• Market Cap: 150.89M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Business 716.97M 78.4%
• Fitness Business 197.74M 21.6%

By Geography

Chart

• Mainland China 696.10M 76.1%
• Singapore 181.19M 19.8%
• Others 20.87M 2.3%
• Taiwan 16.55M 1.8%

Fiscal year ended Dec 31, 2025 See the full Kontafarma China Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	914.71M	17.19M	1.92%
Dec 31, 2024	897.52M	88.41M	10.93%
Dec 31, 2023	809.11M	-84.96M	-9.50%
Dec 31, 2022	894.06M	90.80M	11.30%
Dec 31, 2021	803.27M	-205.87M	-20.40%

Data Source: S&P Global Market Intelligence Last updated: Sep 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 29, 2026

Data Sources Report a data error